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Abstract
Neutrophils are rapidly recruited to sites of tissue injury or infection, where they protect against invading pathogens.
Neutrophil functions are limited by a process of neutrophil senescence, which renders the cells unable to respond to
chemoattractants, carry out respiratory burst, or degranulate. In parallel, aged neutrophils also undergo spontaneous
apoptosis, which can be delayed by factors such as GMCSF. This is then followed by their subsequent removal by
phagocytic cells such as macrophages, thereby preventing unwanted inflammation and tissue damage. Neutrophils
translate mRNA to make new proteins that are important in maintaining functional longevity. We therefore hypothesised
that neutrophil functions and lifespan might be regulated by microRNAs expressed within human neutrophils. Total RNA
from highly purified neutrophils was prepared and subjected to microarray analysis using the Agilent human miRNA
microarray V3. We found human neutrophils expressed a selected repertoire of 148 microRNAs and that 6 of these were
significantly upregulated after a period of 4 hours in culture, at a time when the contribution of apoptosis is negligible. A
list of predicted targets for these 6 microRNAs was generated from http://mirecords.biolead.org and compared to mRNA
species downregulated over time, revealing 83 genes targeted by at least 2 out of the 6 regulated microRNAs. Pathway
analysis of genes containing binding sites for these microRNAs identified the following pathways: chemokine and cytokine
signalling, Ras pathway, and regulation of the actin cytoskeleton. Our data suggest that microRNAs may play a role in the
regulation of neutrophil senescence and further suggest that manipulation of microRNAs might represent an area of future
therapeutic interest for the treatment of inflammatory disease.
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Introduction
Neutrophils are the most abundant white blood cell in the body,
playing an essential role in the destruction of invading bacterial
and fungal pathogens. They are rapidly recruited to sites of injury,
where they extravasate into the tissues and destroy the pathogen
via several mechanisms, including phagocytosis, and the release of
antimicrobial substances [1]. Activated neutrophils also release a
plethora of proinflammatory mediators such as IL-8, IP-10
(CXCL-10) [2] and leukotriene B4 [3], recruiting and activating
further inflammatory cells, thus enhancing the inflammatory
response.
Neutrophil functions are limited by a process of neutrophil
senescence, which renders neutrophils unable to respond to
chemoattractants, carry out respiratory burst, or to degranulate
[4,5]. Senescence is accompanied by an upregulation of CXCR4
on the neutrophil surface and a corresponding increase in ability
to migrate to SDF-1 [6]; these changes home neutrophils back to
the bone marrow where they undergo apoptosis [7]. In parallel,
aged neutrophils can also undergo spontaneous apoptosis, with a
half-life of less than 8 hours [8]. This is followed by their
subsequent removal by phagocytic cells such as macrophages, a
mechanism to prevent unwanted inflammation and tissue damage
[9]. GMCSF is a cytokine with multiple effects on neutrophil
maturation, and on the function of inflammatory neutrophils. The
actions of GMCSF include delaying neutrophil senescence, in part
by the suppression of neutrophil apoptosis [10,11]. Neutrophil
apoptosis is thought to be a major factor in the functional
senescence of neutrophils [11], and the role of changes in protein
expression caused by microRNAs have not to date been
investigated.
The mechanisms of the regulation of neutrophil senescence
have not been well characterised. It is now well known, however,
that neutrophil lifespan is exquisitely regulated both positively and
negatively by interaction with environmental cues such as bacterial
products or cytokines. Rates of neutrophil apoptosis can be
increased by the ingestion of pathogens such as E.coli [12], and
through ligation of cell surface receptors such as Fas [13] and
TRAIL-R2 (DR5) [14]. Conversely, the lifespan of a neutrophil
can be extended through stimulation by inflammatory mediators
such as GMCSF and TNFa[10], with associated functional
longevity of pro-inflammatory and anti-microbial functions [11].
New protein translation is important in maintaining neutrophil
functional viability: blocking either translation or transcription
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increases the rate of neutrophil apoptosis [15,16]. We therefore
hypothesised that dynamic changes in microRNA levels within
neutrophils might regulate proteins instrumental in determining
neutrophil functional longevity.
The pattern of proteins expressed within a cell is thought to be
fine tuned by expression of large numbers of microRNAs, a
recently discovered family of short RNA species that regulate gene
expression using the RNA interference pathway [17]. The
immune system is regulated at many levels by microRNA action,
including differentiation and proliferation of myeloid lineages, and
cellular responses to proinflammatory stimuli [18]. Several recent
studies have reported the presence of microRNAs within human
neutrophils [19,20,21,22], yet their role in defining neutrophil
functions has not been reported. Mature microRNAs are 20–25
nucleotides in length and are produced from a primary transcript
(pri-miRNA), usually several kilobases long, which is cleaved in the
nucleus by Drosha and its cofactor DGCR8 [23] to leave a pre-
miRNA of about 70bp. Pre-miRNA is then transported into the
cytosol by exportin 5 [24] followed by cleavage by Dicer to leave
mature microRNA [25]. There are currently over 850 human
microRNAs (www.miRBase.org V12) and they are thought to
regulate up to 30% of the human genome [26]. Due to incomplete
basepairing with the target sequence, a single microRNA can
target many hundreds of genes, and a single gene can be regulated
by multiple microRNAs, allowing fine tuning of gene transcription
[27]. Key determinants of neutrophil functional longevity, such as
Mcl-1, are known to be regulated by microRNAs in other cell
types [28,29]. We therefore examined changes in microRNA
expression over time and upon treatment with GMCSF in human
neutrophils, revealing for the first time the co-ordinated dynamic
regulation of microRNAs, and hence a range of target genes with
roles in regulation of neutrophil function. This work begins to
identify how neutrophils use microRNAs as one of the tools
available to limit the proinflammatory potential of these essential,
but potentially harmful host defence cells.
Materials and Methods
Neutrophil preparation
Peripheral venous blood was taken with informed consent using
protocols approved by South Sheffield Research Ethics Commit-
tee. South Sheffield Research Ethics Committee specifically
approved this study. All donors gave written consent. Following
dextran sedimentation, Peripheral Blood Neutrophils (PMNs) were
prepared by density centrifugation using OptiprepTM (Axis-Shield,
Upton Huntingdon, UK) [30]. Briefly, leukocyte rich plasma was
resuspended in Hanks’ buffered salt solution (HBSS) + 20% platelet
poor plasma (PPP) and OptiprepTM to give a density of 1.13 g/l.
OptiprepTM /HBSS + 20% PPP was also prepared at 1.095 and
1.080 g/l and layered over the top of the cell suspension, before a
further layer of HBSS + 20% PPP was added. Cells were then
centrifuged at 7006g for 30 minutes before harvesting of the PMN
layer from the 1.095/1.080 interface and further purification by
negative magnetic selection using a custom cocktail mix (Stemcell
Technologies, Vancouver, Canada) [31]. Neutrophils were then left
in culture media for 1 and 4 hours with or without GMCSF (50U/
ml) (Sigma-Aldrich, Poole, UK), followed by preparation of total
RNA. To assess neutrophil purity, duplicate cytospins were
prepared at time 0, and 300 cells per slide were counted as either
neutrophil or non-neutrophil depending on their morphology.
Rates of neutrophil apoptosis were determined through preparation
of cytospins at 20 hours. Duplicate slides were counted blind, and
300 cells per slide were assessed as either apoptotic or non-apoptotic
neutrophils.
RNA preparation
Total RNA was prepared from 3–56106 neutrophils using the
mirVanaTM miRNA isolation kit (Ambion, Huntingdon, UK)
enabling the purification of small RNA species as well. RNA
concentration, 260/280 and 260/230 values were assessed using a
NanoDropH (NanoDrop, Wilmington, DE, USA), and analysis of
RNA integrity was performed using the Agilent 2100 RNA
Bioanalyser (Agilent Technologies, Wokingham, UK) using the
Nano 6000 kit (Agilent Technologies).
MicroRNA microarray and data analysis
A custom microRNA microarray was designed using eArray
(Agilent Technologies) comprising of 2371 different probes for 851
human microRNAs (Agilent Human miRNA microarray V3,
Sanger Database V12). Microarrays were of the 8615K format,
giving 16 replicates for each individual microRNA in each sample.
One hundred nanograms of total RNA was labelled with Cyanine
3-pCp and hybridised to the chip according to the manufacturer’s
instructions. Following careful washing, the arrays were read using
the Agilent microarray scanner and the data were extracted using
Feature Extraction V10.7 (Agilent Technologies).
Extracted data were transferred into Microsoft Excel (Microsoft
Corporation, Reading, UK) where all data were transformed to
Log base 2. Transformed data were then corrected within each
chip using the median percentile shift to 5 abundantly expressed
positive control probes on each array. Data were then further
normalised using the median percentile shift to 2 microRNAs that
were identified to be unregulated across samples using NormFin-
der [32]. The microRNAs identified were miR-16, which has been
previously described as suitable for normalisation in a RT-PCR
study of human breast cancer tissue [33] and miR-720. Fold
change was then simply calculated through the subtraction of one
value from another. Where direct comparisons were performed,
each sample was within the same chip.
Real time PCR
Real time PCR was carried out on total RNA prepared using
the mirVanaTM miRNA isolation kit as described above using 3
different neutrophil donors. The TaqmanH microRNA reverse
transcription kit (Applied Biosystems, Warrington, UK) and
TaqmanH microRNA assays (Applied Biosystems) were used
according to the manufacturer’s instructions and plates were read
using an ABI Prism 7900 Real-Time PCR system (Applied
Biosystems).
Analysis of predicted microRNA binding sites
A list of genes with predicted binding sites for the selected
microRNAs was downloaded from http://mirecords.biolead.org/.
Only those genes that were predicted by at least 3 of the
algorithms were selected. Data were imported into Microsoft Excel
and the target genes were compared with those genes reported to
be downregulated by at least two-fold after 3 or 6 hours in culture
[34]. Those downregulated genes with binding sites for at least 2
out of the 6 selected microRNAs were then subjected to pathway
analysis at http://david.abcc.ncifcrf.gov/tools.jsp [35].
Results
Human neutrophils express a selected repertoire of
microRNAs
To determine the microRNA content of human neutrophils we
carried out a one-colour custom 8615K microarray (Agilent
Technologies) designed to robustly detect all known microRNAs.
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Before preparation of microRNA samples, the purity of the
enriched human neutrophils was assessed by cytospin to be
97.9%60.21 (n = 5, individual purities 98, 97.15, 97.95, 98.25,
98), with the very low level of contaminating cells identified as
eosinophils. Elimination of monocyte contamination is critical in
these experiments, since monocytes have been shown to modulate
neutrophil responses to inflammatory stimuli [36] and may
theoretically contribute disproportionately to the detectable
microRNA population. In contrast, eosinophil contamination
has little functional effect on neutrophils [31], and is unlikely to
contribute significantly to the microRNA profiles seen. However, a
detailed analysis of eosinophil miRNAs has not been published,
and the possibility that some of the findings may be due to
eosinophil contamination cannot be completely excluded. Apop-
tosis rates of the neutrophils at 20 hrs were also assessed by
cytospin and determined to be 62.4%67.4 (n = 5), which is within
the range seen in our laboratory and indicative of low levels of
neutrophil activation [37]. Following preparation of sufficiently
high quality total RNA, samples were labelled, loaded onto the
array slides and read following the manufacturer’s instructions.
The data were extracted using Feature Extraction V10.7 (Agilent
Technologies) and data were transferred into Microsoft Excel for
analysis. In total, 146 out of the 851 microRNAs were found to be
present in at least 4 out of 5 donors, as indicated by the Feature
Extraction software at time 0, with this value increasing to 190 if
the threshold was lowered to 3 out of 5 donors. Figure 1 shows a
heat map of the 25 most abundant microRNAs in 5 human
neutrophil donors. Table S1 shows the microRNAs and their
expression levels of those expressed in at least 4 out 5 human
neutrophil donors. The most abundant microRNA in all samples
tested was miR-223, which negatively regulates granulocyte
differentiation and fine tunes neutrophil function [38].
To validate the microRNA expression levels determined by the
microarray, real time PCR was performed on three further
neutrophil donors (purity 97%60.58; individual purities 97, 96,
98; 20 hrs apoptosis rate 70.8767.47%) on selected microRNAs.
Three microRNAs, miR-223, miR-29a and miR-486-5p were
selected due to their different expression levels: high, medium and
low/absent. The expression of these three microRNAs as
determined by microarray correlated well with the number of
PCR cycles required to reach the threshold, giving an r2 value of
0.9914, p = 0.059 (Figure 2).
Neutrophils express several microRNA clusters
Recent analysis of microRNA transcripts has revealed cluster-
ing, with many microRNAs being transcribed as a single precursor
from a common promoter [39]. Many of these clusters have been
associated with apoptosis and cell survival in cancer [39], therefore
the microarray data were analysed for the expression of such
clusters. We found human neutrophils expressed 11 out of the 25
clusters described by Yu et al [39]. The first such cluster to be
analysed was the miR-17-92 cluster, which is located on
chromosome 13 and contains seven mature microRNAs: miR-17
(17-5p), miR-17* (17-3p), miR-18a, miR-19a, miR-19b, miR-20a
and miR-92a [40]. We found neutrophils expressed five members
of this cluster (expressed in at least 4 out 5 donors), with the absent
members being miR-18a and miR 17* (17-3p) (Figure 3a). The
miR-17-92 cluster has 2 paralogs in mammals, the miR-106b-25
cluster which was found to present in human neutrophils
(Figure 3b) and the miR-106a-363 cluster which was found to
be absent. We also found the miR23a-27a-24 cluster, which has
been reported to regulate both caspase-dependent and indepen-
dent apoptosis [41] (Figure 3c). Two other clusters thought to be
involved in the regulation of apoptosis are the miR-16-1 cluster
Figure 1. Freshly isolated human neutrophils express a discrete repertoire of microRNAs. Total RNA from freshly isolated human
neutrophils (purity 97.9%60.21; apoptosis rates at 20 hours 62.4%67.4; n = 5) were analysed for microRNA expression by microarray. In total 148
microRNAs were found to be present (as indicated by the Feature Extraction software) in at least 4 out 5 donors. The heat map shows the 25 most
abundant microRNAs in freshly isolated human neutrophils.
doi:10.1371/journal.pone.0015810.g001
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and the miR-15b cluster. Both clusters contain the mature miR-
16, but are transcribed from different locations within the genome.
The miR-16-1 cluster is composed of miR-16 and miR-15a, while
the miR-15b cluster is composed of miR-16 and miR-15b. All
three mature microRNAs from these clusters were expressed in
human neutrophils (Figure 3d). Further microRNA clusters found
in human neutrophils were the let7a-1 and let7a-3 clusters
(Figure 3e), the miR-29a and miR-29c clusters (Figure 3f), and
the miR-181a cluster (Figure 3g). Interestingly, human neutrophils
only express miR-181d and not miR-181c of the miR-181c cluster
(Figure 3h).
Regulation of neutrophil microRNAs
Neutrophils are short-lived cells with a limited ability to regulate
gene expression over time [34]. We investigated the regulation of
neutrophil microRNAs over a period of 4 hrs in culture with and
without GMCSF (50U/ml). At this time point negligible rates of
apoptosis are seen, removing a potential confounding variable.
Total RNA was prepared at 0, 1 and 4 hours after purification
(Purity 97.8%60.26; Individual purities 97.15, 98.25, 98; 20 hour
apoptosis rate 73.55%63.39, with GMCSF 46.25%63.19 (n = 3)).
To identify microRNAs that were regulated over time or upon
treatment with GMCSF, only microRNAs that were expressed in
at least 2 out of 3 donors at any one time point or treatment were
selected for analysis. All expression values of Log(2),1 were
rounded up to 1 to remove any large fold changes when the
expression values of the microRNAs were marginal. Figure 4
shows MA plots comparing normalised Log2 expression levels with
the fold regulation, 1hr20hrs (Figure 4a), 4hrs20hrs (Figure 4b),
1hr+GMCSF21hr (Figure 4c) and 4hrs+GMCSF24hrs
(Figure 4d). As might be expected, the majority of neutrophil
microRNAs showed little or no regulation over time or upon
treatment with GMCSF. To determine those microRNAs
regulated in human neutrophils over time or upon treatment with
GMCSF, data were ranked in order of fold change, and those with
an average Log2 fold change of greater than 0.7 (1.62 fold) were
selected for further analysis. In order to prevent undue influence of
any single donor, only microRNAs that were regulated in each
donor by greater than Log2 0.4 fold (1.32 fold) were selected,
before statistical analysis of all 16 replicates for each donor using
the Friedman test with Dunn’s multiple comparison test. After
1 hour in culture, no neutrophil microRNAs were significantly
regulated using this analysis. However, after 4 hours in culture,
significant upregulation was seen for miR-491-3p, miR-34b, miR-
595, miR-328, miR-1281 and miR-483-3p, with no microRNAs
being significantly downregulated. Figure 5 shows the mean data
for the regulation of these microRNAs, with the individual
clustered donors below. Treatment of neutrophils with GMCSF
did not result in the significant regulation of any microRNAs.
Genomic location of regulated microRNAs and potential
functional significance
Of the 6 microRNAs regulated during neutrophil culture, 3 are
located within 3kb of known CpG islands (miRs-1281, 34b and
483-3p), and a further one (miR-328) is located within 10kb (CpG
‘‘shore’’). These are areas of particular sensitivity to regulation by
DNA methylation. This raises the possibility that epigenetic
changes might regulate neutrophil function by changes in
expression of microRNAs. Of further interest is the finding that
3/6 of the regulated microRNAs are within the introns of known
protein coding genes. MiR-328 is in intron 12 on the opposite
strand of the ELMO3 gene, miR-483-3p is within the 39UTR on
the opposite strand of IGF2, while miR-595 is in intron 1 of
PTRN2. Interestingly, miR-153-2 is within intron 19 of PTRN2,
but we were unable to detect this microRNA in our neutrophil
samples. This raises the possibility that these microRNAs may be
co-ordinately regulated with the genes in which introns they are
located. However, microarray expression data is only available for
two of these genes, PTRN2 and IGF2. Interestingly, PTRN2 is
downregulated by the same conditions that cause upregulation of
the intronic microRNA, and IGF2 was not detected in
neutrophils. This suggests that post translational regulation of
mature microRNA generation may be playing a part in the
regulation of protein expression in human neutrophils. Once this
mechanism is understood, this might prove a novel avenue for
therapeutic manipulation of neutrophil function.
Effects of microRNA regulation on neutrophil function
MicroRNAs can influence protein expression by changing
either translation from existing mRNAs, or by influencing mRNA
stability and hence transcript abundance. In order to determine
the possible role of microRNAs in regulating the neutrophil
transcriptome, we compared our data with a published microarray
analysis of transcriptional profile of human neutrophils [34], which
used similar culture conditions and timepoints to our study. By
cross referencing changes in gene expression at mRNA level to our
microRNA analysis we were able to identify regulated genes which
were also predicted targets of regulated microRNAs. Of the
transcripts downregulated in this analysis, 83 contained predicted
binding sites for at least 2 of the 6 microRNAs upregulated after
4 hours (confirmed by at least 3 different algorithms, see Materials
and Methods). This suggests that the observed changes in these
transcripts may be caused by changes in microRNA abundance,
or that changes in transcription and mRNA stability are co-
regulated for these genes. In total, 176 of 602 down-regulated
genes (29%) contained predicted binding sites for at least 1 out of
the 6 microRNAs. Pathway analysis of the down-regulated genes
with at least 2 predicted microRNA binding sites (http://david.
abcc.ncifcrf.gov/tools.jsp [35]) revealed a significant enrichment
(EASE Score p,0.05) of the following pathways: genes involved in
the regulation of inflammation, mediated by chemokine and
Figure 2. Good correlation is seen between microarray and real
time PCR analysis of human neutrophil microRNA. The
expression of 3 different microRNAs, miR-223, miR-29a and miR-486-
5p were analysed by Real Time PCR and compared to the data obtained
from the microarray. Real Time PCR and microarray analysis showed
high correlation, r2 = 0.9914 (p = 0.059). Data are from 3 separate donors
for Real Time PCR (purity 97%60.58; apoptosis rates at 20 hours
70.87%67.47) and 5 separate donors (purity 97.9%60.21; apoptosis
rates at 20 hours 62.4%67.4) for the microarray.
doi:10.1371/journal.pone.0015810.g002
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cytokine signalling; the Ras pathway; and regulation of the actin
cytoskeleton (Table 1). Down-regulation of these pathways in
tandem would reduce the ability of the neutrophil to respond to its
environment – a key feature of senescence. There is also evidence
of targeting of apoptotic pathways by microRNAs: BCL2L11
(BIM), BCLAF and PAK2 all contained binding sites for 4 out of
the 6 microRNAs, although the significance of these remains to be
determined. The potential for these microRNAs to target BIM is
particularly intriguing given the recent observation that BIM
protein is upregulated over time in neutrophils [42]. It is also
interesting to note that the anti-apoptotic BCL-2 family member
Mcl-1, which plays a significant role in regulating neutrophil
lifespan, contained 1 binding site for miR-483-3p. However, no
statistically significant regulation of microRNAs known to target
Mcl-1 [28,29] was identified.
Discussion
Neutrophils are short lived, terminally differentiated leukocytes
that play a critical role in the destruction of invading bacteria and
fungi. Many studies have reported that gene transcription and
protein synthesis are key regulators of neutrophil function [16,43].
MicroRNAs are a recently discovered small RNA species shown to
regulate gene expression and may regulate the expression of up to
30% of all genes [26]. Many microRNAs have been linked to
apoptosis in a variety of cell types and tumours [39]. We therefore
sought to determine the basal expression of microRNAs in freshly-
isolated human neutrophils, their regulation over time, and their
regulation upon treatment with GMCSF, in order to identify novel
regulators of neutrophil functional longevity.
We found highly purified human neutrophils express a distinct
repertoire of microRNAs, with freshly isolated neutrophils (time 0)
expressing 148 out the 851 human microRNAs (www.miRBase.
com V12) in at least 4 out 5 donors on the Agilent Human V3
microRNA microarray. A recent similar array performed on
human neutrophils after subjects had undertaken a bout of
exercise found 282 microRNAs expressed by at least 50% of the
samples in any one out of the two conditions [19]. Using a similar
analysis method we found 261 microRNAs present in at least 2 out
of the 3 samples at any one time point. The most abundant
microRNA in all samples at any time point was miR-223, which
has been shown to be highly expressed in mature neutrophils
[38,44] and to play a role in regulating neutrophil progenitor cell
proliferation and function [38]. MiR-223 was not regulated in
Figure 3. Freshly isolated human neutrophils express cotranscribed microRNA clusters. Total RNA from freshly isolated human
neutrophils (purity 97.9%60.21; apoptosis rates at 20 hours 62.4%67.4; n = 5) were analysed for microRNA expression by microarray. Neutrophils
were found to express 11 cotranscribed microRNA clusters. Expression levels are shown for the following clusters: A) miR-17-92, B) miR-106b-25, C)
miR-23a-27a-24, D) miR-16-1 and miR-15b, E) let-7a-1 and let-7a-3, F) miR-29a and miR-29c, G) miR-181a and H) miR-181c.
doi:10.1371/journal.pone.0015810.g003
Figure 4. Regulation of neutrophil microRNAs. Total RNA from either freshly isolated neutrophils or those in culture for 1 or 4 hours with and
without GMCSF was prepared (purity 97.8%60.26; apoptosis rates at 20 hours 73.55%63.39; with GMCSF 46.25%63.19; n = 3) and were analysed for
microRNA expression by microarray. A) MA plot showing regulation of neutrophil microRNAs after 1 hour in culture. B) MA plot showing the
regulation of microRNAs after 4 hours in culture. C) MA plot showing the regulation of microRNAs after a 1 hour treatment with GMCSF. D) MA plot
showing the regulation of microRNAs after a 4 hour treatment with GMCSF.
doi:10.1371/journal.pone.0015810.g004
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these experiments. Similar results were obtained in a study on
microRNA expression in different hematopoietic lineages using
and real-time PCR to determine the expression levels of 13
microRNAs [22]. Several other recent studies have also reported
microRNA expression in human neutrophils using a variety of
techniques [19,20,21,45]. The next most abundant microRNA in
human neutrophils was miR-720, of which very little is known and
to date has no validated targets. Expression of miR-720 is not
regulated over a wide variety of conditions, and it was identified by
NormFinder as a suitable microRNA for normalisation of
neutrophil data.
Neutrophils also expressed many microRNA clusters, in which
several mature microRNAs are transcribed as a single precursor
[39]. Many of these clusters have been shown to be dysregulated in
many different cancers and to play a role in regulating apoptosis
[46]. The first such cluster to be identified in our array was the
miR-17-92 cluster, of which neutrophils expressed five out of the
seven microRNAs. This is interesting as all seven are transcribed
as one primary transcript, suggesting post-transcriptional regula-
tion of this cluster within neutrophils or their precursors. We found
that the absent members of this cluster were miR-17-3p (miR-17*)
and miR-18a. The absence of both of these was not merely
through non-detection using our custom microarray as studies on
other cell types revealed both miR-18a and miR-17-3p using our
custom array (personal communication, Craig Murdoch, Univer-
sity of Sheffield, UK). The exact function of miR-18a remains
unknown, however one study using lentiviral mediated antagomir
delivery into K562 cells found a positive role for miR-18a in
cellular proliferation [47], possibly explaining its absence in
terminally differentiated non proliferating neutrophils. The role of
miR-17-3p remains unclear. The miR-17-92 cluster has two
Figure 5. Neutrophil microRNAs are significantly upregulated
after 4 hours in culture. Total RNA from either freshly isolated
neutrophils or those in culture for 1 or 4 hours was prepared (purity
97.8%60.26; apoptosis rates at 20 hours 73.55%63.39; n = 3) and were
analysed for microRNA expression by microarray. There were no
microRNAs regulated after 1 hour in culture, however after 4 hours in
culture miR-491-3p, miR-34b, miR-595, miR-328 miR-1281 and miR-483-
3p were significantly upregulated, with none being downregulated.
** indicates p,0.01 and * indicates p,0.05 using the Friedman test
with Dunn’s multiple comparison. The heat map shows the regulation
of the microRNAs in each individual donor at both 1 and 4 hrs.
doi:10.1371/journal.pone.0015810.g005
Table 1. Regulated neutrophil microRNAs target multiple
pathways, potentially downregulating neutrophil
proinflammatory functions.
Inflammation mediated by chemokine and
cytokine signalling pathways
Gene miR Binding Sites
PAK2 4
RHOB 2
PIK3CD 2
ITGAL 2
GNAQ 2
PTEN 2
NFATC3 2
CAMK2G 2
IL8RB 2
Ras pathway
Gene miR Binding Sites
PAK2 4
RHOB 2
PIK3CD 2
MAPKAPK 2
RS6KA3 2
Regulation of actin cytoskeleton
Gene miR Binding Sites
GNA13 2
PAK2 4
PIK3CD 2
VCL 3
ITGAL 2
MSN 2
Total RNA from either freshly isolated neutrophils or those in culture for 1 or
4 hours was prepared (purity 97.8%60.26; apoptosis rates at 20 hours
73.55%63.39; n = 3) and were analysed for microRNA expression by microarray.
Genes potentially regulated by the upregulated microRNAs were downloaded
from www.miRecords.com, and compared with those genes shown to be
regulated over time. Genes within both datasets that were potentially regulated
by at least 2 of the 6 regulated microRNAs were selected and pathway analysis
performed. Pathway analysis of the downregulated genes with at least 2
predicted microRNA binding sites at http://david.abcc.ncifcrf.gov/tools.jsp [35],
revealed a significant enrichment (EASE Score p,0.05) of genes involved
regulation of inflammation mediated by chemokine and cytokine signalling, the
Ras pathway, and the regulation of the actin cytoskeleton.
doi:10.1371/journal.pone.0015810.t001
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paralogs, the miR-106b-25 cluster which was found to be present
in neutrophils and the miR-106a-363 cluster which was absent.
Neutrophils also expressed high levels of the miR23a-27a-24
cluster which has been reported to be anti-apoptotic, with miR-
27a targeting the activity of caspase-3 [48]. Other clusters found in
neutrophils were the miR-16-1 cluster, the miR-15b cluster, the
let-7a-1 and let 7a-3 clusters and the miR-29c and miR29a
clusters. Many of the microRNAs within these clusters have been
suggested to have a role in regulation of the cell cycle and
apoptosis. Indeed over-expression of miR-15b results in cell cycle
arrest in glioma cells [49], the miR-29 family targets Mcl-1 [28],
and let-7a targets caspase-3 [50]. We also found that neutrophils
expressed both members of the miR-181a cluster but only miR-
181d of the miR-181c cluster.
To date there have been two previous studies on the regulation
of microRNAs within human neutrophils, although none have
studied neutrophil microRNA regulation over time or upon
treatment with GMCSF. The first of these reported that miR-9
and miR-9* were upregulated in human neutrophils upon
exposure to LPS [20]. We failed to detect miR-9 and miR-9* in
any sample we arrayed, but we cannot rule out the possibility that
the different techniques used (real time PCR vs microarray) could
explain the differences seen. MiR-9 and miR-9* are highly
expressed in monocytes [20]. Another more recent study used a
similar array to that used in our experiments and identified 38
neutrophil microRNAs that were regulated by exercise [19].
There are currently only validated targets for one of the
microRNAs found to be regulated, miR-328, which targets
ABCG2 [51] and CD44 [52]. This makes defining an exact
function of these microRNAs in neutrophils challenging. Similarly,
siRNA and microRNA-mimic approaches in these fragile
untransfectable cells are not possible with current technology.
Development of a system for efficient miRNA/antagomir delivery
into human neutrophils would have significant potential for
delivering novel therapeutic and scientific advances. To address in
part these shortcomings, we identified functionally valid targets for
those microRNAs through the combination of predictive algo-
rithms and reanalysis of previously published neutrophil micro-
array data [34]. Many of the genes that were downregulated over
3 or 6 hours in the microarray dataset were shown to have
putative binding sites for the regulated microRNAs in their 39
UTR. Pathway analysis of these genes revealed these microRNAs
target pathways involved in the recruitment of neutrophils to sites
of injury [53,54]. This therefore suggests that microRNAs may
regulate the ability of neutrophils to respond to chemotactic and
proinflammatory stimuli, preventing such cells being recruited to
the site of injury – key markers of senescence. It should be noted
that the changes we observe in microRNAs at 4 hours are likely to
be reflected in changes in protein levels and in function at
significantly later timepoints.
We have shown that neutrophils express a selected repertoire of
microRNAs and that a small number of these are regulated over
time as neutrophils begin to undergo senescence/spontaneous
apoptosis. Combining these data with neutrophil transcriptional
profiles and microRNA binding site prediction algorithms has led
us to identify microRNAs likely to play a role in the regulation of
neutrophil senescence. The key targets of microRNAs in
neutrophils remain to be identified; however it remains an
intriguing possibility that therapeutic modulation of neutrophil
function could be achieved through the modulation of microRNA
pathways by microRNA mimics or antagomirs.
Supporting Information
Table S1 Freshly isolated human neutrophils express a
selected repertoire of microRNAs. Total RNA from freshly
isolated human neutrophils (purity 97.9%60.21; apoptosis rates at
20 hours 62.4%67.4; n = 5) were analysed for microRNA
expression by microarray. In total 148 microRNAs were found
to be present (as indicated by the Feature Extraction software) in at
least 4 out 5 donors. The data shown are the normalised Log2
values in descending order of abundance. MiR-223 was the most
abundant in all samples.
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